Vanguard Personalized Indexing Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130M Buy
141,070
+7,253
+5% +$7.35M 1.27% 11
2025
Q4
$144M Buy
133,817
+14,381
+12% +$13.8M 1.4% 11
2025
Q3
$91.2M Sell
119,436
-1,584
-1% -$1.18M 0.93% 12
2025
Q2
$94.4M Buy
121,020
+12,674
+12% +$9.85M 1.07% 12
2025
Q1
$89.5M Buy
108,346
+9,579
+10% +$7.97M 1.32% 10
2024
Q4
$76.2M Sell
98,767
-60
-0.1% -$49.7K 1.15% 12
2024
Q3
$87.6M Buy
98,827
+8,796
+10% +$7.91M 1.41% 8
2024
Q2
$80.5M Buy
90,031
+11,017
+14% +$8.81M 1.53% 7
2024
Q1
$61.5M Buy
79,014
+6,028
+8% +$4.29M 1.32% 7
2023
Q4
$42.5M Buy
72,986
+796
+1% +$465K 1.09% 9
2023
Q3
$38.8M Buy
72,190
+6,851
+10% +$3.53M 1.16% 9
2023
Q2
$30.6M Buy
65,339
+6,753
+12% +$2.83M 0.94% 10
2023
Q1
$20.1M Buy
58,586
+6,473
+12% +$2.18M 0.7% 17
2022
Q4
$19.1M Buy
52,113
+4,087
+9% +$1.45M 0.79% 14
2022
Q3
$15.5M Buy
48,026
+3,613
+8% +$1.14M 0.7% 15
2022
Q2
$14.4M Buy
44,413
+10,195
+30% +$3.06M 0.67% 16
2022
Q1
$9.8M Buy
34,218
+9,418
+38% +$2.42M 0.47% 23
2021
Q4
$6.85M Buy
24,800
+8,569
+53% +$2.17M 0.4% 37
2021
Q3
$3.75M Buy
16,231
+3,177
+24% +$784K 0.34% 46
2021
Q2
$3M Sell
13,054
-2,049
-14% -$412K 0.31% 54
2021
Q1
$2.82M Buy
15,103
+3,964
+36% +$775K 0.43% 37
2020
Q4
$1.88M Sell
11,139
-233
-2% -$34.8K 0.41% 45
2020
Q3
$1.68M Buy
11,372
+1,458
+15% +$226K 0.47% 46
2020
Q2
$1.63M Buy
9,914
+978
+11% +$150K 0.74% 25
2020
Q1
$1.24M Buy
+8,936
New +$1.23M 0.72% 30

Other funds holding LLY

Vanguard Personalized Indexing Management's LLY Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Eli Lilly (LLY) stake by 5.4% in Q1 2026, buying an estimated $7.35M and bringing the position to 141,070 shares worth $130M. The position accounts for 1.27% of the portfolio, ranked #11.

Vanguard Personalized Indexing Management first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $144M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vanguard Personalized Indexing Management held 141,070 shares of Eli Lilly worth $130M as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 7,253 Eli Lilly shares in Q1 2026, an estimated $7.35M.
  • Eli Lilly made up 1.27% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #11 holding.
  • Vanguard Personalized Indexing Management first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Vanguard Personalized Indexing Management's Eli Lilly position peaked at $144M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.